Quetiapine fumarate and Sexual dysfunction - male for People aged 20-29 (a phase IV clinical study of FDA data)

Summary:

Sexual dysfunction - male is found for people aged 20-29 who take Quetiapine fumarate (quetiapine fumarate). This study is created by eHealthMe based on reports of 888 people aged 20-29 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

  • Time on Quetiapine fumarate when people have Sexual dysfunction - male
  • Top conditions
  • Top co-used drugs
  • Top other side effects


On Mar, 08, 2026

888 people aged 20-29 reported to have side effects when taking Quetiapine fumarate.
Among them, 11 people (1.24%) have Sexual dysfunction - male


What is Quetiapine fumarate?

Quetiapine fumarate has active ingredients of quetiapine fumarate. It is often used in insomnia. eHealthMe is studying from 29,525 Quetiapine fumarate users. Check the latest studies of Quetiapine fumarate.

What is Sexual dysfunction - male?

Sexual dysfunction - male (difficulty experienced by male during any stage of a normal sexual activity) is found to be associated with 2,309 drugs and 2,189 conditions by eHealthMe. Check the latest studies of Sexual dysfunction - male.

Number of reports submitted per year:

Could Quetiapine fumarate cause Sexual dysfunction - male in people aged 20-29?

Severity of Sexual dysfunction - male

n/a

How people recovered from Sexual dysfunction - male

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 27.27%
  2. Androgenetic Alopecia (common form of hair loss): 2 people, 18.18%
  3. Stress And Anxiety: 1 person, 9.09%
  4. Psychotic Disorder: 1 person, 9.09%
  5. Drowsiness: 1 person, 9.09%
  6. Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 1 person, 9.09%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

  1. Abilify: 5 people, 45.45%
  2. Risperdal: 5 people, 45.45%
  3. Olanzapine: 4 people, 36.36%
  4. Zyprexa: 4 people, 36.36%
  5. Saphris: 3 people, 27.27%
  6. Latuda: 3 people, 27.27%
  7. Propecia: 2 people, 18.18%
  8. Paliperidone Palmitate: 2 people, 18.18%
  9. Paliperidone: 2 people, 18.18%
  10. Ziprasidone Hydrochloride: 2 people, 18.18%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

  1. Suicide Attempt: 6 people, 54.55%
  2. Suicidal Ideation: 6 people, 54.55%
  3. Stress And Anxiety: 6 people, 54.55%
  4. Drug Ineffective: 4 people, 36.36%
  5. Sedation: 3 people, 27.27%
  6. Blood Prolactin Abnormal: 3 people, 27.27%
  7. Personality Change: 3 people, 27.27%
  8. Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 3 people, 27.27%
  9. Dyskinesia (abnormality or impairment of voluntary movement): 3 people, 27.27%
  10. Disturbance In Social Behavior: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Quetiapine fumarate and have Sexual dysfunction - male?

- Check whether Sexual dysfunction - male is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related publications that referenced our studies:

Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, quetiapine fumarate (the active ingredients of Quetiapine fumarate) and Quetiapine fumarate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: